C34H39n3o8 Cytidine, 5'-O- Ow (4-Methodylyl) Phenylthylyl] -2'-O- (2-Mönchel)

Canonical Laachen O = C1N = C (N) C (= CN1C2OC (CC = 3C = CC = CC3) C & OC = CC = CC = CC = CC = CC = CC = CC = CC = OC4) C
ISOMRIC SMILE C (C4 = CC = C (OC) C = C4) C5 = CC = CC = CC = C2C) N2C = CC = CC = OC3) C = C3) (CC = CI
Inchi
InChI=1S/C34H39N3O8/c1-22-20-37(33(39)36-31(22)35)32-30(43-19-18-40-2)29(38)28(45-32)21-44-34(23-8-6-5-7-9-23,24-10-14-26(4 1-3) 15-11-24) 25-12-16--27 (42-4) 17-, 30---- M1,20,20,20000
Inchi Schlëssel
Lyktvjjxzqtnpk-pbamlimusa-n
24 aner Nimm fir dës Substanz
5'-O- [4-Methodyphonyl) Phenylthyl] -2'-O- (2-Mountcylyl) -5 -5lylcyclett (ACI); 11: PN: US20030170636 Page: 17 behaapt RNA; 12: PN: US20030211606 Page: 18 behaapt R NA; 12: Pn: US20030212017 Säit: 19 behaapt R NA; 14: PN: US20040005569 PAG E: 21 behaapt R NA; 15: PN: US200400056565 Page: 17- 32 Fuerderung RNA; 15: PN: US20040005570 Säit: 19 behaapt R NA; 15: PN: U S20040006030 Page: 22 behaapt R NA; 15: PN: US20040014048 Säit: 19 behaapt R NA; 16: Pn: US200301771313 Säit: 9 Fuerderung RNA; 16: Pn: US20030198965 Säit: 19 behaapt R NA; 16: PN: US20040014047 Page: 19 behaapt R NA; 16: Pn: US20040014049 Säit:

19 behaapt RNA; 17: PN: US200400140516 Page: 21 behaapt R NA; 17: PN: US20040014699 Page: 19 behaapt R NA; 17: PN: W
O03106645 Page: 69 Fuerderung R NA; 18: PN: US20040006029 Page: 22 behaapt R NA; 2'-O-Catecillyl-5'-O-DimethoxytityL-5- Methylytidine; 58: PN: US2003016592 Page: 15 behaapt R NA; 5: PN: WO2005006958 Page: 61 behaapt R NA; 7: Pn: Wo20050 07825 Page: 61 behaapt R NA; 82: PN: US20040171566 Page: 18 behaapt R NA; 89: PN: US20040005707 Säit: 19 behaapt R NA; 9: PN: Wo03084478 Säit: 56 Fuerderung R Na